A living library of credible information for patients of multiple myeloma and their caregivers.
…
continue reading
Multiple Myeloma Podcasts
CancerCare's free Connect Education Workshops are a way for people to learn about cancer-related issues from the convenience of their home or office. Leading experts in oncology provide the most up-to-date information in these workshops to help you and your loved ones better understand and cope with your cancer diagnosis, treatment options, quality-of-life concerns, treatment side effects, pain management, doctor-patient communication and other important topics.
…
continue reading
The Multiple Myeloma Research Foundation provides educational programs to help people with myeloma, family members, caregivers, and healthcare professionals learn more about the disease and today's most promising treatment options, including clinical trials, from leading multiple myeloma doctors and researchers.
…
continue reading
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
…
continue reading
HealthTree Podcast for Multiple Myeloma brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.
…
continue reading
Emergency Medicine Cases – Where the Experts Keep You in the Know. For show notes, quizzes, videos and more learning tools please visit emergencymedicinecases.com
…
continue reading
1
ClinicalXchange Oncology podcasts
Clinical Care Solutions, CCS ClinicalXchange Oncology Podcast
3
4
Welcome to the Clinical Care Solutions Oncology podcast channel. Our podcast shows give you quick access to important content when you need it - at home, at your desk, or on the go.
…
continue reading
Sit back and listen to Ulf-Henrik Mellqvist talking about the significant developments in the field of multiple myeloma treatment. What do the new possibilities mean for patients and doctors? And why should young doctors looking to specialize go into hematology?
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
…
continue reading
In The Hematology Podcast, we dig into the clinical, the theoretical, and the practical, as we discuss the past, present, and future of the hematological field. MAT-DK-2100201(1.0) March 2021
…
continue reading
In the last 20 years, I have lived a life like many, by accident, going to work, go home get paid than the next day starting all over again, living on a proverbial hamster wheel. I can tell you though through coaching and mentorship, I learned that living a life on purpose is less stressful and ensures I am happy more days than not. My goal is to introduce you to guests, ideas, and thoughts that can help you learn that you to can “LIVE YOUR LIFE ON PURPOSE, NOT BY ACCIDENT”.
…
continue reading
The Blood Podcast summarizes content recently published in Blood, the most cited peer-reviewed publication in the field of hematology.
…
continue reading
CancerCare's free Connect Education Workshops are a way for people to learn about cancer-related issues from the convenience of their home or office. Leading experts in oncology provide the most up-to-date information in these workshops to help you and your loved ones better understand and cope with your cancer diagnosis, treatment options, quality-of-life concerns, treatment side effects, pain management, doctor-patient communication and other important topics.
…
continue reading
The Hematologist is the member newsletter of American Society of Hematology (ASH). It is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases. The Hematologist updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.
…
continue reading
Yo, not to get all heavy on you, but this Podcast was born out of my personal experience as a Black man with cancer. I’ve learned a lot... sooo peep this. Black Americans carry a disproportionate cancer burden, including the highest mortality rates from most cancers, and slowest time to diagnosis of any other race. Not only are Black Americans 41% more likely to die from cancer, but they also top the charts in heart disease, diabetes, and obesity too. So, what’s shaking and taking our lives ...
…
continue reading
1
Physicians Practice Pearls: Physician News on Business, Healthcare, Medicine, and Technology
Podcast by Physicians Practice
33
Podcast by Podcast by Physicians Practice
…
continue reading
Wait How Do You Spell That? is a rare disease podcast produced by Patient Worthy. We talk about issues affecting people rare and underdiagnosed conditions and interview advocates from across the community. We‘re definitely not doctors, and we can‘t give you medical advice. We‘re just here to chat and learn about the diseases that even doctors can‘t seem to spell. Check out the latest in rare disease news at PatientWorthy.com.
…
continue reading
Coming Home Well is a podcast hosted by Dr. Tyler Pieron, dedicated to exploring topics that support and uplift the veteran community. The show features engaging conversations with organizations working to assist veterans, discussions with historians about pivotal moments in military history, insights into claims and benefits for service members, and a wide range of other subjects relevant to veterans and their families. Through these discussions, the podcast provides valuable information, g ...
…
continue reading
Welcome to the mibo show, where we focus on mind and body wellness… let’s talk about it!!! Each episode our guests will talk about their mental and/or physical health journey or that of their family. We will also have subject matter experts talk health facts and stats, best practices for wellness, and provide strategies to encourage us all how to live a healthy lifestyle where we prioritize our mind and body wellness on a regular basis!
…
continue reading
The Cancer Revolution podcast series looks to explore all areas of integrative, traditional and alternative means of beating cancer and creating sustained good health, for the young folks and old. Our topics will include areas such as immune system, metabolic theory, epigenetic, microbial connections, diet, mitigating side effects of cancer treatments, detoxification methods, anticancer nutrition, the latest news and stories in institutional cancer research
…
continue reading
Bringing you untold stories behind luminaries and legends of the New York City’s running culture. A new show from the CITIUS MAG Podcast Network. Hosted by Leigh Anne Sharek and Chris Chavez. Support us on Patreon: https://patreon.com/runnersofnyc Be sure to check out CITIUSMAG.com for all your latest running commentary. Support the show and rep Runners of NYC: https://www.bonfire.com/runners-of-nyc-podcast/ ▶ Follow us: twitter.com/RunnersOfNYC | Instagram.com/RunnersOfNYC | Facebook.com/Ci ...
…
continue reading
Audio-reports and interviews done in collaboration with Audio Medica and its founding Editor Peter Goodwin. Audio Medica's Audio Journal of Oncology has been bringing lively listen-in shows to members of the cancer care team in various audio formats since 1992. Scientific Editors are George Canellos, MD, of Dana-Farber Cancer Institute; J. Gordon McVie, MD, of the European Institute of Oncology and Chair of the Editorial Board of OT's UK Edition; Pat Price, MD, of Christie Hospital, also on ...
…
continue reading
1
Cancer Healing Journeys by ZenOnco.io & Love Heals Cancer
Kishan Shah, Vasundhara Raghavan, Nadia Raju, Prabhat Kumar Verma, Imran Shaikh, Vijay Sharnangat, Premitha R, Shreshtha Mittal, Divya Sharma, Bhumi Ben, Divya Par, Farida Rizwan, Asmita Bhattacharya, Sidharth Ghosh
2566
"In life, winning and losing will both happen. What is never acceptable is quitting." When you feel that you are alone in this journey, you really are not alone. There are countless warriors who have gone through a similar journey like what you are going through today; they have felt the immense pain that you are experiencing; but in the end, they have healed themselves from cancer. Some talk about their own journey as you are listening to this, while some have defeated pain forever, but in ...
…
continue reading
1
Special Episode: Eliminating the Need for Sequential Confirmation of Response in Multiple Myeloma
9:47
9:47
Play later
Play later
Lists
Like
Liked
9:47
In this special episode, Dr. Shaji Kumar from the Mayo Clinic speaks with Blood editor Dr. Laurie Sehn on a paper recently published in Blood, "Eliminating the Need for Sequential Confirmation of Response in Multiple Myeloma". The findings demonstrate eliminating the need for sequential confirmation of response in multiple myeloma. The study, invol…
…
continue reading
1
Understanding How Health Care Disparities May Influence Your Cancer Treatment and Care
51:55
51:55
Play later
Play later
Lists
Like
Liked
51:55
- Disproportionate Burden of Cancer & Infectious Diseases on People of Color- Social Determinants of Health, Including Languages Spoken, Health Literacy, Culture, Race, Gender Orientation, LGBTQI+, Religion, Access to Medical Care- Influence of the Local & Regional Environment in Which You Live- How Race May Impact Your Access to Oncology Care, Tre…
…
continue reading
1
Multiple Myeloma — Fourth Annual National General Medical Oncology Summit
50:41
50:41
Play later
Play later
Lists
Like
Liked
50:41
Clinical investigators discuss available data guiding the management of multiple myeloma. CME information and select publications here.By Dr. Neil Love
…
continue reading
1
A key role for T-cell TET3 in chronic GVHD; a BTK inhibitor for ITP; co-inhibition of pre-TCR and IL-7R pathways in a T-ALL patient subset
20:30
20:30
Play later
Play later
Lists
Like
Liked
20:30
In this week's episode, we' ll learn about how TET3 has a key role in GVHD. In mice, a deficiency of Tet3 in donor T cells inhibited pathogenic immunoglobulin class switching and suppressed lung fibrosis. Accordingly, TET3 may be a new therapeutic target in chronic GVHD. After that: rilzabrutinib, a BTK inhibitor for ITP. In a randomized, placebo-c…
…
continue reading
1
Myelofibrosis — Year in Review Series on Relevant New Datasets and Advances
59:18
59:18
Play later
Play later
Lists
Like
Liked
59:18
Professor Claire Harrison from the Guy’s and St Thomas’ NHS Foundation Trust in London, United Kingdom, and Dr John Mascarenas from The Tisch Cancer Institute in New York, New York, provide their perspectives on relevant new clinical data in myelofibrosis and discuss their application to treatment. CME information and select publications here.…
…
continue reading
1
012 Treatment Without Transplant: What Older Myeloma Patients Need to Know
32:05
32:05
Play later
Play later
Lists
Like
Liked
32:05
Welcome to The Myeloma Minutes. This episode explores the standard treatment for older or transplant-ineligible patients with myeloma, focusing on the DRD regimen, its side effects, and supportive care options. 📌Key points: The DRD combo (Daratumumab, Lenalidomide, Dexamethasone) can keep myeloma controlled for years—even in older patients. Steroid…
…
continue reading
1
From Cubicle to Costa Rica: How Ryan Mellon Crafted His Digital Nomad Dream
1:03:14
1:03:14
Play later
Play later
Lists
Like
Liked
1:03:14
Are you ready to break free from the 9-to-5 grind and embrace a life of adventure and freedom? In this eye-opening episode, I sit down with Ryan Mellon, a digital nomad who has mastered the art of location-independent living. Ryan shares his inspiring journey from working grueling 14-hour days to traveling the world while building multiple business…
…
continue reading
1
Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances
59:08
59:08
Play later
Play later
Lists
Like
Liked
59:08
Dr Stephen Ansell from Mayo Clinic in Rochester, Minnesota, and Dr Brian Hill from Cleveland Clinic Taussig Cancer Institute in Ohio summarize major treatment advances over the past year and review relevant ongoing clinical trials for patients with non-Hodgkin lymphoma. CME information and select publications here.…
…
continue reading
1
How I Treat Series on Geriatric Hematology
17:19
17:19
Play later
Play later
Lists
Like
Liked
17:19
In this How I Treat Series episode Dr. Thomas Ortel leads a discussion with author Dr. Patrick Foy on his paper “How I diagnose and treat thrombocytopenia in geriatric patients”. See the full How I Treat series on geriatric hematology in volume 143 issue 3 of Blood Journal.By American Society of Hematology
…
continue reading
1
Single cell multi-omic analysis of leukemia stem cells, cyclophosphamide for non-immune effector cell-associated neurotoxicity, and glycosylation as a mediator of von Willebrand factor clearance
16:06
16:06
Play later
Play later
Lists
Like
Liked
16:06
In this week's episode, we’ll learn more about the identification and characterization of stem cell-like leukemia blasts using single cell multi-omics, cyclophosphamide as a treatment for non-immune effector cell-associated neurotoxicity in patients treated with B-cell maturation antigen, or BCMA, targeted CAR T-cell therapies, and how differences …
…
continue reading
1
011 Understanding Induction Therapy for Myeloma
34:42
34:42
Play later
Play later
Lists
Like
Liked
34:42
Welcome to The Myeloma Minutes. This episode guides you as a patient or carer through induction therapy for myeloma, focusing on the DVTD regimen, its side effects, supportive treatments, and how to manage them. 💡You'll learn: How four powerful drugs work together to fight myeloma — and why you don’t need to suffer through side effects. That neurop…
…
continue reading
1
Emerging Treatments for Metastatic Melanoma
59:45
59:45
Play later
Play later
Lists
Like
Liked
59:45
- Overview of Metastatic Melanoma, Including Diagnosing & Staging- New Treatment Approaches- Targeted Therapy & the Role of Precision Medicine- The Role of Immunotherapy- Clinical Trial Updates- Follow-Up Care- Tips for Caring for Your Skin During Cancer Treatments, Including Sun & Wind Safety Recommendations- Controlling Side Effects, Symptoms, Di…
…
continue reading
1
EM Quick Hits 65 Occipital Nerve Block, PoCUS in Pulmonary Embolism, Myelopathy, Team Resuscitation, Incidental Neutropenia, Peer Programs
1:08:14
1:08:14
Play later
Play later
Lists
Like
Liked
1:08:14
On this month's EM Quick Hits podcast: Dr. Mathew MacArther on Occipital Nerve Block, Dr. Ian Chernoff on PoCUS in Pulmonary Embolism, Dr. Hans Rosenberg on Myelopathy, Dr. Shawn Segeren on Team Resuscitation, Dr. Brit Long on Incidental Neutropenia and Dr. Kylie Booth on Peer Programs. Please help ensure continued Free Open Access of the entire EM…
…
continue reading
1
Read Your Way to the Top: Books and Stories to Inspire Your Journey with Dennis Henson
1:38:08
1:38:08
Play later
Play later
Lists
Like
Liked
1:38:08
If you're feeling stuck in life, constantly on autopilot, and wondering why you're not making progress towards your goals, then you are not alone! Despite having the desire to achieve more, many individuals find themselves trapped in a cycle of comfort and monotony that holds them back from pursuing their dreams. It's time to break free from this p…
…
continue reading
1
Understanding How Health Care Disparities May Influence Your Cancer Treatment and Care
51:55
51:55
Play later
Play later
Lists
Like
Liked
51:55
- Disproportionate Burden of Cancer & Infectious Diseases on People of Color- Social Determinants of Health, Including Languages Spoken, Health Literacy, Culture, Race, Gender Orientation, LGBTQI+, Religion, Access to Medical Care- Influence of the Local & Regional Environment in Which You Live- How Race May Impact Your Access to Oncology Care, Tre…
…
continue reading
1
Systemic Mastocytosis and Myelofibrosis — Fourth Annual National General Medical Oncology Summit
47:55
47:55
Play later
Play later
Lists
Like
Liked
47:55
Clinical investigators discuss available data guiding the management of systemic mastocytosis and myelofibrosis. CME information and select publications here.By Dr. Neil Love
…
continue reading
1
New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancer
56:00
56:00
Play later
Play later
Lists
Like
Liked
56:00
- Overview of Advanced Skin Cancers, Including Basal Cell & Squamous Cell Cancers- New Treatment Approaches- Emerging Role of Targeted Therapy- Clinical Trial Updates- Managing Treatment Side Effects, Discomfort & Pain- Tips for Caring for Your Skin During Cancer Treatments- Sun & Wind Safety Tips- Communicating with Your Health Care Team About Qua…
…
continue reading
1
Role of the Multidisciplinary Team in Achieving Comprehensive and Individualized Care of Patients with HR-positive/HER2-negative Metastatic Breast Cancer and Preexisting Comorbidities
35:15
35:15
Play later
Play later
Lists
Like
Liked
35:15
In this podcast episode, Sara A. Hurvitz, MD, FACP, La-Urshalar B. Brock, FNP-BC, CNM, and Jordan Hill, PharmD, BCOP, discuss the important role of the multidisciplinary team in achieving comprehensive and individualized care of patients with HR-positive/HER2-negative metastatic breast cancer and preexisting comorbidities, including: Key Comorbidit…
…
continue reading
1
New insights on PU.1-mutated agammaglobulinemia; venetoclax-based induction therapy in younger AML patients; the link between ABO Blood groups and risk of future VTE
19:46
19:46
Play later
Play later
Lists
Like
Liked
19:46
In this week's episode, we'll hear about new insights into PU.1-mutated agammaglobulinemia. Researchers show that haploinsufficiency of the master transcriptional regulator PU.1 causes agammaglobulinemia and dendritic cell deficiencies. These patients experience an array of infectious and non-infectious complications, but not leukemia. After that: …
…
continue reading
1
Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
50:50
50:50
Play later
Play later
Lists
Like
Liked
50:50
Dr Rafael Fonseca from Mayo Clinic in Phoenix, Arizona, discusses datasets from the 2024 ASH meeting on the management of newly diagnosed and relapsed/refractory multiple myeloma. CME information and select publications here.By Dr. Neil Love
…
continue reading
1
010 The First Steps in Myeloma Care: What to Expect and Why It Matters
29:52
29:52
Play later
Play later
Lists
Like
Liked
29:52
Welcome to The Myeloma Minutes. During this episode, Drs Jam and Sally provide a clear and compassionate guide to first-line treatment for multiple myeloma. 💡You'll learn: About 'induction', 'consolidation' and 'maintenance'—and why they matter. Why pathways can often be dictated by age/health. ...And that the aim isn’t just survival—it’s living we…
…
continue reading
1
Rewiring Your Money Mindset A Path to Financial Freedom with Dwight Heck
56:10
56:10
Play later
Play later
Lists
Like
Liked
56:10
Are you struggling with financial stress that's pushing you towards unhealthy coping mechanisms? In this raw and honest episode, I dive deep into the complex relationship between money worries and addictive behaviors, offering insights and strategies to break free from this destructive cycle. Drawing from personal experiences and years of financial…
…
continue reading
1
Chronic Lymphocytic Leukemia — An Interview with Dr Lindsey Roeker on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
48:22
48:22
Play later
Play later
Lists
Like
Liked
48:22
Dr Lindsey Roeker from Mayo Clinic in Rochester, Minnesota, discusses recent updates on available and novel treatment strategies for chronic lymphocytic leukemia. CME information and select publications here.By Dr. Neil Love
…
continue reading
1
Dual BCR::ABL1 Inhibition Shows Promise in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
18:31
18:31
Play later
Play later
Lists
Like
Liked
18:31
In this episode, Contributing Editor Scott Furlan, MD, PhD, an assistant professor at the Fred Hutch Cancer Center and Department of Pediatrics at the University of Washington in Seattle, talks with Daniel J. DeAngelo, MD, PhD, chief of the leukemia division at the Dana-Farber Cancer Institute and a professor of medicine at Harvard Medical School i…
…
continue reading
1
Relapsed/Refractory Follicular Lymphoma Part 3 — A Roundtable Discussion on the Selection and Sequencing of Other Novel Therapies
42:34
42:34
Play later
Play later
Lists
Like
Liked
42:34
Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma. CME informati…
…
continue reading
1
How I Treat Transfusion Medicine (part 2)
33:57
33:57
Play later
Play later
Lists
Like
Liked
33:57
In part two of the How I Treat Series on Transfusion Medicine Dr. Erica Wood interviews the "How I Manage Major Hemorrhage" author group: Drs. Jeannie Callium, Keyvan Karkouti, and Ron George. Find the full published review series in Volume 145 Issue 20 of Blood Journal.By American Society of Hematology
…
continue reading
1
Clonal hematopoiesis in frequent blood donors, immune microenvironment and bispecific antibody response in diffuse large B-cell lymphoma, and blinatumomab as part of early consolidation therapy in CD19 ...
20:57
20:57
Play later
Play later
Lists
Like
Liked
20:57
In this week's episode we’ll learn about how frequent blood donation affects clonal hematopoiesis in older, male blood donors; the effect of immune microenvironment on response to bispecific antibodies in diffuse large B-cell lymphoma; and the feasibility of adding blinatumomab to early consolidation therapy in CD19-positive Ph-negative B-cell acut…
…
continue reading
1
009 Bone Disease, Bisphosphonates & Myeloma: What You Need to Know
28:07
28:07
Play later
Play later
Lists
Like
Liked
28:07
Welcome to The Myeloma Minutes. This episode explores how bone disease affects people with multiple myeloma and how bisphosphonates like zolendronic acid can help manage pain, prevent fractures, and support treatment. 📌 Three Big Takeaways Bone disease isn’t inevitable in myeloma—but needs fast action when it strikes! Zolendronic acid can protect y…
…
continue reading
1
Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies
49:54
49:54
Play later
Play later
Lists
Like
Liked
49:54
Dr Jennifer Crombie from the Dana-Farber Cancer Institute in Boston, Massachusetts, reviews available and investigational CD20 x CD3 targeted bispecific antibodies for the treatment of follicular and diffuse large B-cell lymphomas. CME information and select publications here.By Dr. Neil Love
…
continue reading
1
Raising Your Vibration and Breaking Free from Destructive Habits with Mary Beth Schrudder
1:10:34
1:10:34
Play later
Play later
Lists
Like
Liked
1:10:34
Are you struggling with addiction and seeking a path to recovery that goes beyond traditional methods? In this eye-opening episode, I sit down with Mary Beth Schrudder, a spiritual and transformational life coach who has overcome her own battles with alcohol, food, and toxic relationships. Mary Beth shares her powerful journey from corporate execut…
…
continue reading
Send us a text The integration of artificial intelligence (AI) into routine clinical practice is poised to revolutionize the diagnosis and treatment of hematologic diseases. AI-based models are already capable of automatically identifying cell populations including malignant cells, and facilitating early disease detection and prognosis. However, th…
…
continue reading
1
Relapsed/Refractory Follicular Lymphoma Part 2 — A Roundtable Discussion on the Selection and Sequencing of CAR T-Cell Therapy
37:08
37:08
Play later
Play later
Lists
Like
Liked
37:08
Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma. CME informati…
…
continue reading
1
Uncovering Safety and Signposts to the Future: AEs With HER2-Targeted ADCs and Future Applications
21:54
21:54
Play later
Play later
Lists
Like
Liked
21:54
In this episode, Catherine Fahey, MD, PhD; Alexandra Leary, MD, PhD; Funda Meric-Bernstam, MD; and Zev A. Wainberg, MD, discuss the evolving safety considerations and future directions of HER2-targeted antibody–drug conjugates (ADCs) across genitourinary, gastrointestinal, and gynecologic cancers. Toxicity Profiles of HER2-Targeted ADCs: Common and…
…
continue reading
1
When to STOP Treatment for Immune Thrombocytopenia in Patients Experiencing a Complete Response on Thrombopoietin Receptor Agonists
10:34
10:34
Play later
Play later
Lists
Like
Liked
10:34
In this episode, Contributing Editor Michael Scott, MD, a hematologist at St. Michael’s Hospital in Toronto, Canada, and an assistant professor at the University of Toronto, talks with Marc Michel, MD, MSc, head of the internal medicine and clinical immunology department at Henri Mondor University Hospital in Créteil, France. They talk about long-t…
…
continue reading
1
How I Treat Transfusion Medicine (part 1)
32:12
32:12
Play later
Play later
Lists
Like
Liked
32:12
In this two-part series, Dr. Erica Wood talks with Drs. Masja de Haas, Helen Savoia, and Stella Chou about their articles in the How I Treat Series on Transfusion Medicine. Topics include noninvasive prenatal testing for red blood cell and platelet antigens, transfusion cases in sickle cell disease, and pregnant patients who are alloimmunized to RB…
…
continue reading
1
Discontinuing lenalidomide maintenance in MM; congenital neutropenia syndrome linked to COPZ1 mutations; low GVHD rates with ruxolitinib after allogeneic HCT
18:15
18:15
Play later
Play later
Lists
Like
Liked
18:15
In this week's episode, we'll learn about stopping myeloma maintenance therapy in the modern era. New research suggests that many patients in remission can discontinue lenalidomide, remaining treatment-free, without jeopardizing disease response. After that: a novel congenital neutropenia syndrome. Mutations in the COPZ1 gene impact myeloid differe…
…
continue reading
1
008 Scans and Myeloma : What you need to know, with Dr Shaheel Bhuva
44:16
44:16
Play later
Play later
Lists
Like
Liked
44:16
Welcome to The Myeloma Minutes. Dr Shaheel Bhuva, a radiologist (and long term colleague of Jam) joins Drs Jam and Sally to demystify scans in myeloma—explaining what they show, when they're used, and he'll dispel some myths around harmful amounts of radiation! 3 Key Teakaways: Not all bone damage shows up on X-rays—some scans reveal disease before…
…
continue reading
- Overview of Follicular Lymphoma- Treatment Options for Newly Diagnosed- Treatment Options for Relapsed/Refractory Disease- Clinical Trial Updates: How Research Increases Treatment Options- New & Emerging Treatments- Factors that May Affect Treatment Planning- Side Effect Prevention & Management- Tips to Improve Communicating with the Health Care …
…
continue reading
1
The Limitless You Escaping the Social Trance and Embracing Self Love with Yvonne Trost
1:10:10
1:10:10
Play later
Play later
Lists
Like
Liked
1:10:10
Are you ready to embark on a journey of self-discovery and personal transformation? In this enlightening episode, I sit down with Yvonne Trost, a transformational coach, international speaker, and hypnotherapist who left her high-powered corporate career to help people uncover the happiness and purpose they never thought possible. Yvonne shares her…
…
continue reading
1
Ep 204 High Risk Pulmonary Embolism Management
1:24:06
1:24:06
Play later
Play later
Lists
Like
Liked
1:24:06
There are many nuances in the management of patients with pulmonary embolism in cardiac arrest, peri-arrest or simply in shock: We need to optimize oxygenation and airway management, hemodynamic support, acid/base management, thrombolysis and/or catheter-directed therapies that Anton dives into with guest experts Dr. Lauren Westafer, Dr. Bourke Til…
…
continue reading
1
Non-Hodgkin Lymphoma — Fourth Annual National General Medical Oncology Summit
50:03
50:03
Play later
Play later
Lists
Like
Liked
50:03
Clinical investigators discuss available data guiding the management of non-Hodgkin lymphoma. CME information and select publications here.By Dr. Neil Love
…
continue reading
1
Advances in the Treatment of Gastric Cancer
57:50
57:50
Play later
Play later
Lists
Like
Liked
57:50
- Overview of Gastric Cancer, Including Diagnosis & Staging- Current Standard of Care, Including Chemotherapy- New Treatment Approaches & the Role of Targeted Treatment & Immunotherapy- Precision Medicine: Predicting Response to Treatment- The Role of Clinical Trials: How Research Contributes to Treatment Options- Controlling Treatment Side Effects…
…
continue reading
1
Non-Hodgkin Lymphoma — An Interview with Dr John P Leonard on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
52:36
52:36
Play later
Play later
Lists
Like
Liked
52:36
Dr John P Leonard from Weill Cornell Medicine in New York, New York, reviews data presented at the 2024 ASH Annual Meeting and their implications for the treatment of non-Hodgkin lymphomas. CME information and select publications here.By Dr. Neil Love
…
continue reading
1
Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
1:00:44
1:00:44
Play later
Play later
Lists
Like
Liked
1:00:44
- Overview of Diffuse Large B-Cell Lymphoma- Staging & Grading- Current Standard of Care- Treatment Options for Resistant Disease- New & Emerging Treatment Approaches- The Role of Clinical Trials- How Research Contributes to Treatment Choices- Tips to Manage Treatment Side Effects, Symptoms, Discomfort & Pain- The Increasing Role of Telehealth/Tele…
…
continue reading
1
Measurable residual disease and maintenance therapy in acute myeloid leukemia (AML), stemness and chemotherapy resistance in AML, and effects of babesiosis on red blood cells in sickle cell disease
19:58
19:58
Play later
Play later
Lists
Like
Liked
19:58
In this week's episode, we’ll learn more about how measurable residual disease might help guide decisions about post-transplant gilteritinib maintenance in FLT3-ITD acute myeloid leukemia, or AML; how stemness contributes to chemotherapy resistance in AML; and effects of babesiosis on red blood cells from individuals with sickle cell disease, sickl…
…
continue reading
1
007 Smouldering Myeloma : Risks and monitoring - A Patient's guide
36:16
36:16
Play later
Play later
Lists
Like
Liked
36:16
Welcome to The Myeloma Minutes. During this episode Jam and Sally deep dive into Smouldering Myeloma—explaining what it is, how it’s monitored, the emotional toll of uncertainty, and what patients and carers can expect from evolving research and care approaches. Conversation points include: Smouldering myeloma is a precancerous condition and it nee…
…
continue reading
1
Overcoming Multiple Myeloma: How Storytelling, Emotional Intelligence, and Empathy Transformed Ray Hartjen’s Life
1:45:14
1:45:14
Play later
Play later
Lists
Like
Liked
1:45:14
Have you ever wondered how emotional intelligence, empathy, and the power of storytelling can help you overcome life’s biggest challenges? In this inspiring episode, I sit down with Ray Hartjen — a writer, musician, marketer, and cancer patient advocate — who shares his compelling cancer survivor story and journey through multiple myeloma. With ove…
…
continue reading
1
Taking a New Path: Evaluating Clinical Data With HER2-Targeted ADCs in Genitourinary, Gastrointestinal, and Gynecological Malignancies
29:36
29:36
Play later
Play later
Lists
Like
Liked
29:36
In this episode, Catherine Fahey, MD, PhD; Alexandra Leary, MD, PhD; Funda Meric-Bernstam, MD; and Zev A. Wainberg, MD, explore the mechanisms of HER2-targeted antibody–drug conjugates (ADCs) and emerging clinical data with these agents across genitourinary, gastrointestinal, and gynecologic cancers. Mechanisms of action of ADCs: how ADCs selective…
…
continue reading
1
Metastatic Breast Cancer: Treatment Updates
1:05:14
1:05:14
Play later
Play later
Lists
Like
Liked
1:05:14
- Overview of Metastatic Breast Cancer- Current Standard of Care- New Treatment Approaches- Updates on Clinical Trials- How Clinical Research Increases Your Treatment Options- Biomarkers, Diagnostic Testing & Technologies: Why They Are Important in Informing Treatment Decisions for Metastatic Breast Cancer- Preventing & Managing Treatment Side Effe…
…
continue reading
1
Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances
59:14
59:14
Play later
Play later
Lists
Like
Liked
59:14
Dr Jennifer R Brown from Dana-Farber Cancer Institute in Boston and Prof Paolo Ghia from IRCCS Ospedale San Raffaele in Milano, Italy, summarize clinically relevant research findings and datasets over the past year regarding the treatment of chronic lymphocytic leukemia. CME information and select publications here.…
…
continue reading
